Skip to content

Clinical trials

Completed Phase 3 Neurodegenerative Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodegenerative Diseases Phase: Phase 3 Status: Completed Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20112
20122
20131
20162
20181
20191
20202
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
GenSight Biologics3
Medivation, Inc.2
TauRx Therapeutics Ltd2
Assistance Publique - Hôpitaux de Paris1
Eisai Co., Ltd.1
Eisai Limited1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodegenerative Diseases15
Nervous System Diseases9
Alzheimer Disease8
Brain Diseases8
Dementia7
Central Nervous System Diseases6
Movement Disorders4
Parkinson Disease4
Parkinsonian Disorders4
Cognitive Dysfunction3

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.